IL324784A - Humanized il-10 receptor binding molecules and methods of use - Google Patents
Humanized il-10 receptor binding molecules and methods of useInfo
- Publication number
- IL324784A IL324784A IL324784A IL32478425A IL324784A IL 324784 A IL324784 A IL 324784A IL 324784 A IL324784 A IL 324784A IL 32478425 A IL32478425 A IL 32478425A IL 324784 A IL324784 A IL 324784A
- Authority
- IL
- Israel
- Prior art keywords
- humanized
- methods
- receptor binding
- binding molecules
- molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363506798P | 2023-06-07 | 2023-06-07 | |
| US202363511122P | 2023-06-29 | 2023-06-29 | |
| PCT/US2024/033162 WO2024254567A2 (en) | 2023-06-07 | 2024-06-07 | Humanized il-10 receptor binding molecules and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324784A true IL324784A (en) | 2026-01-01 |
Family
ID=93796492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324784A IL324784A (en) | 2023-06-07 | 2025-11-19 | Humanized il-10 receptor binding molecules and methods of use |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2024286534A1 (en) |
| IL (1) | IL324784A (en) |
| WO (1) | WO2024254567A2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107216389B (en) * | 2016-03-18 | 2022-03-29 | 和迈生物科技有限公司 | anti-PD-L1 nano antibody and coding sequence and application thereof |
| JP7743500B2 (en) * | 2020-08-05 | 2025-09-24 | シンセカイン インコーポレイテッド | IL10 receptor binding molecules and methods of use |
-
2024
- 2024-06-07 WO PCT/US2024/033162 patent/WO2024254567A2/en active Pending
- 2024-06-07 AU AU2024286534A patent/AU2024286534A1/en active Pending
-
2025
- 2025-11-19 IL IL324784A patent/IL324784A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024254567A2 (en) | 2024-12-12 |
| AU2024286534A1 (en) | 2025-12-04 |
| WO2024254567A3 (en) | 2025-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL305944A (en) | Agonistic anti-il-2r antibodies and methods of use | |
| IL275243A (en) | Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof | |
| IL317655A (en) | Fcrn/antigen-binding molecules and methods of use | |
| EP4192880A4 (en) | Il10 receptor binding molecules and methods of use | |
| IL316368A (en) | Anti-tl1a antibodies and methods of use thereof | |
| IL316065A (en) | Anti-cd28 antibodies and methods of use thereof | |
| IL315714A (en) | Bispecific antibody fusion molecules and methods of use thereof | |
| IL315845A (en) | Anti-dectin-1 antibodies and methods of use thereof | |
| IL319674A (en) | Humanized anti-il-1r3 antibody and methods of use | |
| IL317690A (en) | Anti-gpnmb antibodies and methods of use thereof | |
| IL318694A (en) | Anti-ccr8 antibodies and methods of use | |
| IL324784A (en) | Humanized il-10 receptor binding molecules and methods of use | |
| CA3293252A1 (en) | Humanized il-10 receptor binding molecules and methods of use | |
| GB202319605D0 (en) | Monovalent binding molecules and methods of use | |
| IL317637A (en) | Anti-steap1 antigen-binding molecules and uses thereof | |
| IL319590A (en) | Multispecific antibodies and methods of use thereof | |
| CA3284529A1 (en) | Antigen binding molecules and methods of use | |
| IL320671A (en) | Anti-fgfr3 antibodies and antigen-binding fragments and methods of use thereof | |
| IL318357A (en) | Anti- il27r antibodies and methods of use thereof | |
| IL316700A (en) | Anti-bmp9 antibodies and methods of use thereof | |
| IL316894A (en) | Anti-tnfr2 antibodies and methods of use thereof | |
| IL321679A (en) | Anti-ror-2 antibodies and methods of use | |
| HK40104314A (en) | Anti-cd3 antibodies and methods of use thereof | |
| EP4010697A4 (en) | Antigen binding molecules and methods of screening thereof | |
| CA3288202A1 (en) | Il-10 receptor antibodies and methods of use thereof |